ADIM
HCA icon

Alpha DNA Investment Management’s HCA Healthcare HCA Stock Holding History

Alpha DNA Investment Management’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,139
Closed -$869K – 216
2024
Q3 		$869K Buy
+2,139
New +$783K 0.33% 65
2021
Q1 		– Sell
-52
Closed -$8K – 732
2020
Q4 		$8K Buy
+52
New +$7.6K 0.01% 319

Other funds holding HCA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha DNA Investment Management's HCA Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of HCA Healthcare (HCA) in Q4 2024, closing a stake of 2,139 shares — an estimated $869K sold.

Alpha DNA Investment Management first reported a position in HCA in Q4 2020 and held it in 2 quarters. The position peaked at $869K in Q3 2024. 1,180 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining HCA Healthcare position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,139 HCA Healthcare shares in Q4 2024, an estimated $869K.
  • Alpha DNA Investment Management first reported a position in HCA Healthcare in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's HCA Healthcare position peaked at $869K in Q3 2024.
  • 1,180 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.